简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2012-11-12 15:43 ABRAXANE® Demonstrates Statistically Significant Improvement in Overall Survival for Patients with Advanced Pancreatic Cancer in Phase III Study
2012-11-09 15:23 KCI Sells Therapeutic Support Systems™ Business to Getinge AB
2012-11-08 10:08 Cirrus HD-OCT Record Number of 10,000 Installations and Prestigious Award for OCT Inventors
2012-11-07 14:33 Taiho Pharmaceutical Unveils Data on Eight Novel Anticancer Compounds in Bid to Become a New Global Leader in Oncology
2012-11-06 17:41 ICON Launches New Functional Service Provision (FSP) Strategy
2012-11-06 15:05 Quintiles Study Confirms Validity of Data from Patients Recruited Over the Internet
2012-11-05 21:15 PerkinElmer Launches New Epigenetic Cellular Detection Research Kits at its Revolutionaries for Global Health Summit
2012-11-04 03:30 Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
2012-11-02 14:16 TTP054, a Novel, Orally Active Drug for Glucose Control, Progresses towards Completion of a Phase 2 Proof-of-Concept Clinical Trial in Type 2 Diabetics
2012-10-30 16:05 Novel, Oral Drug TTP488 Shows Promise for Disease Modification in Alzheimer’s Patients
2012-10-29 16:45 Cegedim Relationship Management Mobile Intelligence Features Full Compatibility with Windows 8
2012-10-26 14:29 8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012
2012-10-25 10:17 Policy Makers Join the Call for the Prevention of Atrial Fibrillation-Related Strokes to be Made a National Healthcare Priority
2012-10-24 15:56 Quintiles Expands Patient Access for Clinical Trials to Indonesia
2012-10-19 14:41 GE Healthcare Connects People through Music in Fight Against Breast Cancer with First Health Initiative powered by Spotify
2012-10-17 15:30 WIN Consortium and Oracle Join Forces to Accelerate Personalized Cancer Care
2012-10-17 12:32 Major Breakthrough in Malaria Reduction, and Reduction of Mosquito Bites Now Possible with New Receptor-Blocking Chemical Technologyc
2012-10-17 10:00 Cegedim Relationship Management Releases Mobile Intelligence 8, Groundbreaking Cloud-Based CRM + CLM + Data Platform
2012-10-15 20:00 Eppendorf Announces New Brunswick CelliGen® BLU cabinet / 50L CelliGen® BLU vessel
2012-10-15 18:16 FAB’ENTECH launches a Phase I clinical trial in Singapore for its new product against H5N1 Avian Influenza

Business Wire Weibo

Press Releases

Latest Releases